FOLH1 and prostate cancer: Wei et al. reported two prostate cancer patients with known brain metastases who underwent 68Ga-PSMA-11 (HBED-CC) PET imaging for restaging and demonstrated distinct 68Ga-PSMA-11 (HBED-CC) uptake in the cerebral lesions [63].